Phibro Animal Health (NASDAQ:PAHC) Announces Quarterly Earnings Results

Phibro Animal Health (NASDAQ:PAHC) posted its earnings results on Wednesday. The company reported $0.79 EPS for the quarter, topping analysts’ consensus estimates of $0.78 by $0.01, FiscalAI reports. Phibro Animal Health had a net margin of 6.57% and a return on equity of 37.86%. The firm had revenue of $386.77 million during the quarter, compared to analysts’ expectations of $382.42 million.

Phibro Animal Health Trading Up 4.7%

NASDAQ:PAHC traded up $1.78 during mid-day trading on Wednesday, hitting $39.43. 266,659 shares of the company’s stock were exchanged, compared to its average volume of 203,145. The company has a 50 day simple moving average of $37.16 and a 200-day simple moving average of $41.09. The company has a current ratio of 2.96, a quick ratio of 1.27 and a debt-to-equity ratio of 1.84. Phibro Animal Health has a fifty-two week low of $28.25 and a fifty-two week high of $60.08. The firm has a market capitalization of $1.60 billion, a P/E ratio of 11.73 and a beta of 0.42.

Phibro Animal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 16th. Investors of record on Wednesday, November 25th will be issued a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 1.2%. The ex-dividend date is Wednesday, November 25th. Phibro Animal Health’s dividend payout ratio (DPR) is 19.67%.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on PAHC. Weiss Ratings raised shares of Phibro Animal Health from a “hold (c+)” rating to a “buy (b-)” rating in a report on Monday. Zacks Research raised shares of Phibro Animal Health from a “hold” rating to a “strong-buy” rating in a research note on Friday, September 18th. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Buy” and a consensus price target of $47.67.

About Phibro Animal Health

Phibro Animal Health Corporation develops, manufactures and sells products designed to support the health, nutrition and productivity of food-producing animals. Its offerings include animal health products, vaccines, medicated feed additives, nutritional specialties and performance products used in livestock, poultry and aquaculture.

The company’s products are intended to help prevent and manage disease, improve animal well-being and support efficient food production. Phibro serves producers, veterinarians, feed manufacturers and distributors through a portfolio that includes pharmaceuticals, vaccines, mineral and nutritional supplements, and other feed and water solutions.

Phibro Animal Health markets its products internationally across a broad range of geographic regions, including North America, Latin America, Europe, Asia-Pacific and other global markets.